BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35606596)

  • 1. Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics.
    Liu Q; Zhu F; Liu X; Lu Y; Yao K; Tian N; Tong L; Figge DA; Wang X; Han Y; Li Y; Zhu Y; Hu L; Ji Y; Xu N; Li D; Gu X; Liang R; Gan G; Wu L; Zhang P; Xu T; Hu H; Hu Z; Xu H; Ye D; Yang H; Li B; Tong X
    Nat Metab; 2022 May; 4(5):559-574. PubMed ID: 35606596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untargeted metabolomics as an unbiased approach to the diagnosis of inborn errors of metabolism of the non-oxidative branch of the pentose phosphate pathway.
    Shayota BJ; Donti TR; Xiao J; Gijavanekar C; Kennedy AD; Hubert L; Rodan L; Vanderpluym C; Nowak C; Bjornsson HT; Ganetzky R; Berry GT; Pappan KL; Sutton VR; Sun Q; Elsea SH
    Mol Genet Metab; 2020; 131(1-2):147-154. PubMed ID: 32828637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel transketolase inhibitor oroxylin A suppresses the non-oxidative pentose phosphate pathway and hepatocellular carcinoma tumour growth in mice and patient-derived organoids.
    Jia D; Liu C; Zhu Z; Cao Y; Wen W; Hong Z; Liu Y; Liu E; Chen L; Chen C; Gu Y; Jiao B; Chai Y; Wang HY; Fu J; Chen X
    Clin Transl Med; 2022 Nov; 12(11):e1095. PubMed ID: 36314067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transketolase in human Müller cells is critical to resist light stress through the pentose phosphate and NRF2 pathways.
    Chen Y; Zhang T; Zeng S; Xu R; Jin K; Coorey NJ; Wang Y; Wang K; Lee SR; Yam M; Zhu M; Chang A; Fan X; Zhang M; Du J; Gillies MC; Zhu L
    Redox Biol; 2022 Aug; 54():102379. PubMed ID: 35779441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transketolase Deficiency Protects the Liver from DNA Damage by Increasing Levels of Ribose 5-Phosphate and Nucleotides.
    Li M; Lu Y; Li Y; Tong L; Gu XC; Meng J; Zhu Y; Wu L; Feng M; Tian N; Zhang P; Xu T; Lin SH; Tong X
    Cancer Res; 2019 Jul; 79(14):3689-3701. PubMed ID: 31101762
    [No Abstract]   [Full Text] [Related]  

  • 6. Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner.
    Qin Z; Xiang C; Zhong F; Liu Y; Dong Q; Li K; Shi W; Ding C; Qin L; He F
    J Exp Clin Cancer Res; 2019 Apr; 38(1):154. PubMed ID: 30971297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma.
    Ahmad F; Dixit D; Sharma V; Kumar A; Joshi SD; Sarkar C; Sen E
    Cell Death Dis; 2016 May; 7(5):e2213. PubMed ID: 27148686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of transketolase promotes the anti-diabetic role of brown adipose tissues.
    Ji Y; Liu W; Zhu Y; Li Y; Lu Y; Liu Q; Tong L; Hu L; Xu N; Chen Z; Tian N; Wu L; Zhu L; Tang S; Zhang P; Tong X
    J Endocrinol; 2023 Mar; 256(3):. PubMed ID: 36449405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of transketolase as a target of PARIS in substantia nigra.
    Kim H; Kang H; Lee Y; Park CH; Jo A; Khang R; Shin JH
    Biochem Biophys Res Commun; 2017 Nov; 493(2):1050-1056. PubMed ID: 28939041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transketolase counteracts oxidative stress to drive cancer development.
    Xu IM; Lai RK; Lin SH; Tse AP; Chiu DK; Koh HY; Law CT; Wong CM; Cai Z; Wong CC; Ng IO
    Proc Natl Acad Sci U S A; 2016 Feb; 113(6):E725-34. PubMed ID: 26811478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
    Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
    Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
    [No Abstract]   [Full Text] [Related]  

  • 12. Transketolase Deficiency in Adipose Tissues Protects Mice From Diet-Induced Obesity by Promoting Lipolysis.
    Tian N; Liu Q; Li Y; Tong L; Lu Y; Zhu Y; Zhang P; Chen H; Hu L; Meng J; Feng M; Li M; Zheng L; Li B; Xu T; Wu L; Tong X
    Diabetes; 2020 Jul; 69(7):1355-1367. PubMed ID: 32295803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective deletion of Eos (Ikzf4) in T-regulatory cells leads to loss of suppressive function and development of systemic autoimmunity.
    Gokhale AS; Gangaplara A; Lopez-Occasio M; Thornton AM; Shevach EM
    J Autoimmun; 2019 Dec; 105():102300. PubMed ID: 31296356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape.
    Chorro L; Suzuki M; Chin SS; Williams TM; Snapp EL; Odagiu L; Labrecque N; Lauvau G
    Nat Commun; 2018 Dec; 9(1):5368. PubMed ID: 30560927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TKTL1 Knockdown Impairs Hypoxia-Induced Glucose-6-phosphate Dehydrogenase and Glyceraldehyde-3-phosphate Dehydrogenase Overexpression.
    Baptista I; Karakitsou E; Cazier JB; Günther UL; Marin S; Cascante M
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
    Zhang B; Chikuma S; Hori S; Fagarasan S; Honjo T
    Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8490-5. PubMed ID: 27410049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity.
    Luo CT; Liao W; Dadi S; Toure A; Li MO
    Nature; 2016 Jan; 529(7587):532-6. PubMed ID: 26789248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic control of thymic Treg-cell development.
    Kitagawa Y; Ohkura N; Sakaguchi S
    Eur J Immunol; 2015 Jan; 45(1):11-6. PubMed ID: 25348287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIM2 in regulatory T cells restrains autoimmune diseases.
    Chou WC; Guo Z; Guo H; Chen L; Zhang G; Liang K; Xie L; Tan X; Gibson SA; Rampanelli E; Wang Y; Montgomery SA; Brickey WJ; Deng M; Freeman L; Zhang S; Su MA; Chen X; Wan YY; Ting JP
    Nature; 2021 Mar; 591(7849):300-305. PubMed ID: 33505023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of transketolase triggers a stringent metabolic response in promastigotes and loss of virulence in amastigotes of Leishmania mexicana.
    Kovářová J; Pountain AW; Wildridge D; Weidt S; Bringaud F; Burchmore RJS; Achcar F; Barrett MP
    PLoS Pathog; 2018 Mar; 14(3):e1006953. PubMed ID: 29554142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.